UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Link to "El español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts
We’re Hiring! Are you ready to shape the future of healthcare technology? Join Corify Care to revolutionize cardiovascular care and improve patient outcomes worldwide. 🌍

We are seeking a highly skilled and experienced Senior Software Developer to lead the development of innovative software solutions for our advanced...

Read More »
Corify Care secures €6 million to accelerate the expansion of its revolutionary non-invasive cardiac mapping technology

Corify Care, the medical technology company transforming the diagnosis and treatment of cardiac arrhythmias, has announced the close of a €3 million...

Read More »
Acorys at the XXI Course of ablation and navigation systems

Last week, Corify Care was invited to participate in the XXI Course of ablation and navigation systems at the Instituto de Investigación...

Read More »